Cargando…

Estimates and trends of the global burden of NASH-related liver cancer attributable to high fasting plasma glucose in 1990–2019: analysis of data from the 2019 Global Burden of Disease Study

BACKGROUND: Experimental and epidemiological studies have indicated an association between diabetes exposure and an increased risk of liver cancer due to nonalcoholic steatohepatitis (NASH). However, to date, no systematic study has specifically investigated the burden of NASH-related liver cancer d...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ziyi, Yang, Na, He, Liyun, Wang, Jialu, Ping, Fan, Li, Wei, Xu, Lingling, Zhang, Huabing, Li, Yuxiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843876/
https://www.ncbi.nlm.nih.gov/pubmed/36647090
http://dx.doi.org/10.1186/s13098-022-00976-w
_version_ 1784870493133733888
author Li, Ziyi
Yang, Na
He, Liyun
Wang, Jialu
Ping, Fan
Li, Wei
Xu, Lingling
Zhang, Huabing
Li, Yuxiu
author_facet Li, Ziyi
Yang, Na
He, Liyun
Wang, Jialu
Ping, Fan
Li, Wei
Xu, Lingling
Zhang, Huabing
Li, Yuxiu
author_sort Li, Ziyi
collection PubMed
description BACKGROUND: Experimental and epidemiological studies have indicated an association between diabetes exposure and an increased risk of liver cancer due to nonalcoholic steatohepatitis (NASH). However, to date, no systematic study has specifically investigated the burden of NASH-related liver cancer due to exposure to high fasting plasma glucose (HFPG) levels worldwide. METHODS: The number and rate of deaths and disability-adjusted life years (DALYs) from HFPG-induced NASH-related liver cancer were estimated based on the results of the 2019 Global Burden of Disease Study. The estimated annual percentage changes (EAPCs) for age-standardized death or DALYs rates were calculated using a generalized linear model with a Gaussian distribution to quantify the temporal trends in the global burden of NASH-related liver cancer attributable to HFPG. The strength and direction of the association between the sociodemographic index (SDI) and death or DALY rate were measured using Spearman’s rank-order correlation. RESULTS: Globally, approximately 7.59% of all DALY and 8.76% of all mortalities of NASH-related liver cancer in 2019 were due to HFPG. The age-standardized death and DALY rates of NASH-related liver cancer attributable to HFPG increased from 1990 to 2019. The corresponding EAPCs were 0.69 (95% UI 0.48–0.89), and 0.30 (95% UI 0.05–0.56), respectively. This increasing pattern was most obvious in the high- and low-SDI regions. The age-standardized mortality and DALYs rate of NASH-related liver cancer attributable to HFPG varies considerably worldwide, with the middle SDI region having the highest death and DALY rates in 2019 (DALY 0.96 [95% UI 0.23–2.18]; death 0.05 [95% UI 0.01–0.11]). CONCLUSION: The burden of NASH-related liver cancer attributable to HFPG has increased over the past three decades, particularly in regions with high and low SDI. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13098-022-00976-w.
format Online
Article
Text
id pubmed-9843876
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-98438762023-01-18 Estimates and trends of the global burden of NASH-related liver cancer attributable to high fasting plasma glucose in 1990–2019: analysis of data from the 2019 Global Burden of Disease Study Li, Ziyi Yang, Na He, Liyun Wang, Jialu Ping, Fan Li, Wei Xu, Lingling Zhang, Huabing Li, Yuxiu Diabetol Metab Syndr Research BACKGROUND: Experimental and epidemiological studies have indicated an association between diabetes exposure and an increased risk of liver cancer due to nonalcoholic steatohepatitis (NASH). However, to date, no systematic study has specifically investigated the burden of NASH-related liver cancer due to exposure to high fasting plasma glucose (HFPG) levels worldwide. METHODS: The number and rate of deaths and disability-adjusted life years (DALYs) from HFPG-induced NASH-related liver cancer were estimated based on the results of the 2019 Global Burden of Disease Study. The estimated annual percentage changes (EAPCs) for age-standardized death or DALYs rates were calculated using a generalized linear model with a Gaussian distribution to quantify the temporal trends in the global burden of NASH-related liver cancer attributable to HFPG. The strength and direction of the association between the sociodemographic index (SDI) and death or DALY rate were measured using Spearman’s rank-order correlation. RESULTS: Globally, approximately 7.59% of all DALY and 8.76% of all mortalities of NASH-related liver cancer in 2019 were due to HFPG. The age-standardized death and DALY rates of NASH-related liver cancer attributable to HFPG increased from 1990 to 2019. The corresponding EAPCs were 0.69 (95% UI 0.48–0.89), and 0.30 (95% UI 0.05–0.56), respectively. This increasing pattern was most obvious in the high- and low-SDI regions. The age-standardized mortality and DALYs rate of NASH-related liver cancer attributable to HFPG varies considerably worldwide, with the middle SDI region having the highest death and DALY rates in 2019 (DALY 0.96 [95% UI 0.23–2.18]; death 0.05 [95% UI 0.01–0.11]). CONCLUSION: The burden of NASH-related liver cancer attributable to HFPG has increased over the past three decades, particularly in regions with high and low SDI. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13098-022-00976-w. BioMed Central 2023-01-17 /pmc/articles/PMC9843876/ /pubmed/36647090 http://dx.doi.org/10.1186/s13098-022-00976-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Li, Ziyi
Yang, Na
He, Liyun
Wang, Jialu
Ping, Fan
Li, Wei
Xu, Lingling
Zhang, Huabing
Li, Yuxiu
Estimates and trends of the global burden of NASH-related liver cancer attributable to high fasting plasma glucose in 1990–2019: analysis of data from the 2019 Global Burden of Disease Study
title Estimates and trends of the global burden of NASH-related liver cancer attributable to high fasting plasma glucose in 1990–2019: analysis of data from the 2019 Global Burden of Disease Study
title_full Estimates and trends of the global burden of NASH-related liver cancer attributable to high fasting plasma glucose in 1990–2019: analysis of data from the 2019 Global Burden of Disease Study
title_fullStr Estimates and trends of the global burden of NASH-related liver cancer attributable to high fasting plasma glucose in 1990–2019: analysis of data from the 2019 Global Burden of Disease Study
title_full_unstemmed Estimates and trends of the global burden of NASH-related liver cancer attributable to high fasting plasma glucose in 1990–2019: analysis of data from the 2019 Global Burden of Disease Study
title_short Estimates and trends of the global burden of NASH-related liver cancer attributable to high fasting plasma glucose in 1990–2019: analysis of data from the 2019 Global Burden of Disease Study
title_sort estimates and trends of the global burden of nash-related liver cancer attributable to high fasting plasma glucose in 1990–2019: analysis of data from the 2019 global burden of disease study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843876/
https://www.ncbi.nlm.nih.gov/pubmed/36647090
http://dx.doi.org/10.1186/s13098-022-00976-w
work_keys_str_mv AT liziyi estimatesandtrendsoftheglobalburdenofnashrelatedlivercancerattributabletohighfastingplasmaglucosein19902019analysisofdatafromthe2019globalburdenofdiseasestudy
AT yangna estimatesandtrendsoftheglobalburdenofnashrelatedlivercancerattributabletohighfastingplasmaglucosein19902019analysisofdatafromthe2019globalburdenofdiseasestudy
AT heliyun estimatesandtrendsoftheglobalburdenofnashrelatedlivercancerattributabletohighfastingplasmaglucosein19902019analysisofdatafromthe2019globalburdenofdiseasestudy
AT wangjialu estimatesandtrendsoftheglobalburdenofnashrelatedlivercancerattributabletohighfastingplasmaglucosein19902019analysisofdatafromthe2019globalburdenofdiseasestudy
AT pingfan estimatesandtrendsoftheglobalburdenofnashrelatedlivercancerattributabletohighfastingplasmaglucosein19902019analysisofdatafromthe2019globalburdenofdiseasestudy
AT liwei estimatesandtrendsoftheglobalburdenofnashrelatedlivercancerattributabletohighfastingplasmaglucosein19902019analysisofdatafromthe2019globalburdenofdiseasestudy
AT xulingling estimatesandtrendsoftheglobalburdenofnashrelatedlivercancerattributabletohighfastingplasmaglucosein19902019analysisofdatafromthe2019globalburdenofdiseasestudy
AT zhanghuabing estimatesandtrendsoftheglobalburdenofnashrelatedlivercancerattributabletohighfastingplasmaglucosein19902019analysisofdatafromthe2019globalburdenofdiseasestudy
AT liyuxiu estimatesandtrendsoftheglobalburdenofnashrelatedlivercancerattributabletohighfastingplasmaglucosein19902019analysisofdatafromthe2019globalburdenofdiseasestudy